Extrovis Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 1.44 M
as on 31-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.11 Cr
as on 31-07-2024
- Satisfied Charges ₹ 15.00 Cr
as on 31-07-2024
- Revenue 197.41%
(FY 2023)
- Profit 156.50%
(FY 2023)
- Ebitda 186.41%
(FY 2023)
- Net Worth 32.70%
(FY 2023)
- Total Assets 259.68%
(FY 2023)
About Extrovis
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.44 M.
The company currently has active open charges totaling ₹43.11 Cr. The company has closed loans amounting to ₹15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prasada Gollapudi, Gottumukkula Raju, Hanumantha Kamma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304TG2017FTC115706
- Company No.
115706
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
07 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Extrovis?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanumantha Kamma  | Director | 05-Jun-2021 | Current |
| Prasada Gollapudi | Director | 01-Aug-2019 | Current |
| Gottumukkula Raju | Additional Director | Current | |
| Bezawada Prasad | Whole-Time Director | 10-Oct-2022 | Current |
Financial Performance of Extrovis.
Extrovis Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 197.41% increase. The company also saw a substantial improvement in profitability, with a 156.5% increase in profit. The company's net worth Soared by an impressive increase of 32.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Extrovis?
In 2023, Extrovis had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ambesten Pharmaceuticals Private LimitedActive 9 years 6 monthsPrasada Gollapudi is a mutual person
- Beltree Lifesciences India Private LimitedActive 2 years 4 days
Gottumukkula Raju and Bezawada Prasad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Nov 2023 | ₹22.50 Cr | Open |
Others Creation Date: 14 Nov 2023 | ₹7.50 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Apr 2023 | ₹1.46 M | Open |
How Many Employees Work at Extrovis?
Extrovis has a workforce of 241 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Extrovis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Extrovis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
